Showing results (341-350 of 804) with videos related to
Sort By:
Pageof 81
Experimental Biology and Medicine (Maywood, N.J.)|August 29, 2015
The impact of acute aerobic exercise on chitinase 3-like protein 1 and intelectin-1 expression in obesityChun-Jung Huang, Aaron L Slusher, Michael Whitehurst, et al.Science (New York, N.Y.)|January 29, 1971
ynergy of ethanol and a natural soporific--gamma hydroxybutyrateE R McCabe, E C Layne, D F Sayler, et al.The Prostate|April 30, 1999
Characterization of the enzymatic activity of PSM: comparison with brain NAALADaseC W Tiffany, R G Lapidus, A Merion, et al.ACS Medicinal Chemistry Letters|August 29, 2025
Prodrugs 2-(Phosphonomethyl)pentanedioic Acid (2-PMPA) as Orally Available Glutamate Carboxypeptidase II InhibitorsNiyada Hin, Chae Bin Lee, Sadakatali Gori, et al.Journal of Pediatric Gastroenterology and Nutrition|August 1, 1996
Growth hormone insensitivity in children with biliary atresiaJ C Bucuvalas, J A Horn, J Slusher, et al.The Journal of Emergency Medicine|April 12, 2008
Association of injury visits in children and child maltreatment reportsMaria I Spivey, Patricia G Schnitzer, Robin L Kruse, et al.The American Journal of Tropical Medicine and Hygiene|November 9, 2019
The Minnesota Model: A Residency Global Health Track FrameworkMichael B Pitt, Tina M Slusher, Sophia P Gladding, et al.Brain Research|January 31, 2016
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosisKristen R Hollinger, Jesse Alt, Alison M Riehm, et al.ACS Medicinal Chemistry Letters|November 20, 2014
Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase InhibitorsSarah C Zimmermann, Rana Rais, Jesse Alt, et al.Neurochemical Research|November 22, 2019
Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the BrainJames J Vornov, Diane Peters, Mike Nedelcovych, et al.Pageof 81